Fate Therapeutics Stock Price - FATE

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Fate Therapeutics Inc FATE NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 17.86 0.00 0.00 0.00 17.86 05:24:44
Bid Price Ask Price Spread Spread % News
17.01 18.85 1.84 9.76% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Fate Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.17B 65.39M $ -66.60M -1.19 - 64.39M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Fate Therapeutics News

Loading Messages....

Latest FATE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FATE Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week17.5418.3216.7517.6209728k0.321.82%
1 Month18.4419.3714.64917.4584870k-0.58-3.15%
3 Months20.4922.8214.64919.3285757k-2.63-12.84%
6 Months17.9822.8214.64918.7019699k-0.12-0.67%
1 Year13.5622.821116.7084738k4.331.71%
3 Years3.0322.821.812.0282508k14.83489.44%
5 Years5.2222.821.4610.5385368k12.64242.15%

Fate Therapeutics Description

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.


Your Recent History
NASDAQ
FATE
Fate Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.